Neuroscan is a company founded by neuroscientists with a primary mission to support the needs of investigators, in both the research and clinical domains. For over 15 years, research and development has remained the primary focus of Neuroscan.  From creating the world's first complete hardware and software package for acquiring and processing EEG and ERP data to developing the industry standard in quality amplifiers, Neuroscan has strived to provide advanced solutions for research on the leading edge of science.

Comprehensive Solutions

Neuroscan recognizes the importance of providing comprehensive solutions for research.   Each component in the Neuroscan family of products integrates seamlessly with the others, allowing the selection of only those tools that meet your current needs, secure in the knowledge that a clear upgrade path exists when your requirements necessitate expansion.  From the most basic EEG recordings to sensory, perceptual and cognitive ERPs, from source localization to integration with MRI data or even simultaneous recording with fMRI, the evolution of the Neuroscan product line continues.

Developing solutions that support a wide variety of applications is no small task. Starting with the most basic processing tools that are common to all EEG applications, Neuroscan has not only incorporated these algorithms but has sought to optimize and improve these processes.  For instance, eye artifact reduction is a necessary part of all EEG data processing, and Neuroscan provides four methods for reduction, including a proprietary spatial filter method that allows unlimited flexibility.   

Beyond basic data processing, Neuroscan has incorporated an extensive array of analysis tools and is constantly assessing and incorporating the latest processing algorithms to provide the neuroscience community with the most advanced tools for their research.  For instance, event related coherence and event-related synchronization /de-synchronization have been standard features of SCAN software since the late 1990s.  Additional advanced analysis tools included real time source analysis with generalized boundary and finite element head models, real time independent components analysis and filtering, and soon to be added, wavelet denoising and decomposition.

Functional Neuroimaging

One major focus of our current R&D efforts is in the area of functional neuroimaging.  Two separate research groups have taken different approaches to advanced EEG and ERP to produce true functional neuroimaging integration. 

Our source reconstruction group in Hamburg, Germany, consisting of Dr. Manfred Fuchs, Ph.D., Dr. Michael Wagner, Ph.D. and Jörn Kastner, have recently developed advanced algorithms for source analysis that provide noise-based confidence estimates (patent-pending) for dipole source localization. This innovation and a comprehensive array of advanced analytic tools will be combined with a new Windows-based interface for Curry 5.  The interface under development will provide a usable tool for the clinician as well as the most advanced processing and analysis algorithms for the most critical researcher.  Advances in the accuracy and usability of source localization will allow this technique to be more widely used for more applications greatly advancing the development of the field.

Real time integration of EEG and fMRI acquisition is the focus of the second research and development team based in El Paso, Texas. To facilitate this development, active international collaborations have been established with some of the most advanced fMRI facilities in the world.  Ultimately, the combined temporal resolution of EEG and ERPs and spatial accuracy of fMRI will provide neuroscientists with an unprecedented capacity to explore sensory, perceptual and cognitive processes in normal and pathological populations.  While the MagLink system is currently available and in use in many research labs, ongoing development will make application in clinical environments feasible as well. 

Part of the ongoing development of the MagLink system has been the creation of the SynAmps² amplifier system.  Designed to deal with the rigorous task of simultaneously acquiring EEG and fMRI data, the SynAmps² will enhance the ability to record and correct artifacts associated with recording in the MRI environments.    The latest release of the SCAN software, 4.3, also plays a critical role, providing software tools for artifact reduction and removal.

Together, the R&D groups in Hamburg and El Paso as well as with our new parent company, Compumedics, in Melbourne, Australia will provide the capacity for highly accurate recordings and real time source localization both in and out of the MRI environment.  The foundation of such a progressive system is already in place, with the existing Neuroscan products.  

For additional details please contact sales@neuro.com.